CVE Intelligence
Skip to main content
MEDIUM

CVE-2021-33846

CVE-2021-33846 — Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algorithm

Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) version 2.0.1.3 issues authentication tokens to authenticated users that are signed with a symmetric encryption key. An attacker in possession of the key can issue valid JWTs and impersonate arbitrary users.

Published Updated Sources: cvelistV5, icscert

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

0%

chance of exploitation in 30 days

Affects

fresenius kabi

vigilant_software_suite_mastermed_dashboard

CVSS base

5.9

MEDIUM

CISA SSVC assessment

Three decision points CISA publishes for the CVEs it assesses · SSVC 2.0.3. A stakeholder decision, not a severity score.

CISA

Exploitation

None

none · proof-of-concept · active

Automatable

No

can an attacker script all four kill-chain steps

Technical impact

Total

partial · total control of the vulnerable component

Affected scope

The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.

Vendors (1)

Products (1)

vigilant software suite mastermed dashboard

Every base score collected

Sources score independently and disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactSource
5.9CVSS 3.1MEDIUM——cvelistV5

Weakness & attack patterns

  • CWE-327

Attack patterns reported against this CVE. The ATT&CK techniques below are inferred from its weakness class.

  • T1036.001Masquerading: Invalid Code Signature
  • T1553.002Subvert Trust Controls: Code Signing

References

1 on the record

Elsewhere on this site

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.